EG626682 Inhibitors
Defa28, a predicted alpha defensin, is anticipated to play a role in protein homodimerization and participate in various cellular processes, including responses to lipopolysaccharide, defense against other organisms, and the positive regulation of membrane permeability. Predicted to be active in extracellular spaces, Defa28 is located in intracellular membrane-bounded organelles and the midbody, suggesting versatile roles in cellular functions. Orthologous to human genes DEFA3 and DEFA6, Defa28's predicted functions align with its potential involvement in innate immune responses and cellular homeostasis.
Inhibition of Defa28 can be approached through direct or indirect means, considering its predicted involvement in various cellular processes and intracellular locations. Direct inhibition may involve compounds targeting specific aspects of Defa28 function, such as disrupting its homodimerization activity or blocking its interaction with other proteins. However, as specific inhibitors for Defa28 are not identified, indirect inhibition emerges as an alternative strategy. Modulating cellular processes and pathways linked to Defa28, such as the PI3K pathway, endosomal functions, or ion transport, may influence its localization, activity, and overall involvement in defense responses. The presented inhibitors, ranging from sodium channel blockers to MAPK pathway modulators, offer a diverse set of tools to explore the intricate regulatory network surrounding Defa28, shedding light on its potential role in innate immunity and cellular defense mechanisms. The complexity of Defa28's functions, spanning intracellular and extracellular domains, underscores the importance of investigating both direct and indirect modes of inhibition to unravel the full spectrum of its contributions to cellular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibits protein transport from endoplasmic reticulum to Golgi apparatus by targeting the ADP-ribosylation factor (ARF). May indirectly impact Defa28 intracellular trafficking and secretion by disrupting the normal secretory pathway. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Sodium ionophore disrupting ion gradients in cells. Its impact on intracellular membrane-bounded organelles may indirectly influence Defa28's predicted location within these organelles, potentially affecting its cellular functions. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin polymerization, potentially affecting cellular processes such as membrane dynamics and vesicular trafficking. Indirectly, Cytochalasin D may impact Defa28 localization and alter its activity by influencing the cytoskeletal structure. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor disrupting intracellular signaling. Given Defa28's predicted involvement in cellular responses, Wortmannin's impact on the PI3K pathway may indirectly modulate Defa28 activity in response to lipopolysaccharide or other stimuli. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Inhibits microtubule polymerization, affecting cellular structure and processes. Disruption of microtubules by Colchicine may indirectly influence Defa28 localization and activity, potentially altering its involvement in defense responses and permeability regulation. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Sodium channel blocker influencing ion transport. By altering ion gradients, Amiloride may indirectly affect Defa28's involvement in positive regulation of membrane permeability, potentially impacting its role in cellular defense responses. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Alters endosomal pH, affecting intracellular processes. Chloroquine's impact on endosomal functions may indirectly influence Defa28 trafficking and secretion, potentially affecting its extracellular activity in defense responses. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Blocks aldosterone receptors, affecting ion transport and cellular functions. Spironolactone's impact on ion regulation may indirectly influence Defa28's predicted involvement in positive regulation of membrane permeability and cellular defense responses. | ||||||
FCM Lysing solution (1x) | sc-3621 | 150 ml | $62.00 | 8 | ||
Alters endosomal pH, affecting intracellular processes. Similar to Chloroquine, NH4Cl may indirectly influence Defa28 trafficking and secretion, potentially impacting its extracellular activity in defense responses. | ||||||
PD 169316 | 152121-53-4 | sc-204168 sc-204168A sc-204168B sc-204168C | 1 mg 5 mg 10 mg 25 mg | $88.00 $156.00 $281.00 $461.00 | 3 | |
p38 MAPK inhibitor affecting MAPK signaling. Since Defa28 is predicted to respond to lipopolysaccharide, SB203580's modulation of the p38 MAPK pathway may indirectly influence Defa28 function during cellular responses to this microbial component. | ||||||